Side-by-side images show lung ultrasound pinpoints same findings as low-dose chest CT.
Radiologists can potentially avoid exposing patients suspected of COVID-19 infection to unnecessary radiation. New images reveal findings from a lung ultrasound correlated closely with those of a chest CT.
Published in Intensive Care Medicine, side-by-side images of the two scans reveal both scans identify the same findings and lead to the same diagnosis.
The images came from a 54-year-old man who presented to Hôpital Nord in Marseille, France, with fever, cough, and shortness of breath that had lasted for four days. Both a low-dose chest CT and the RT-PCR test were conducted, resulting in a positive COVID-19 diagnosis. Providers completed a lung ultrasound, as well, after he was admitted to the intensive care unit due to oxygenation failure.
When compared the lung ultrasound and chest CT both reveal similar areas of pulmonary involvement and the pattern of parenchymal disease.
The transverse thoracic CT image shows multi-lobar asymmetric lung lesions with peripheral distribution of ground-glass opacities, consolidation, and crazy pavement pattern. The lung ultrasound images (shown as thumbnails alongside the CT scan) indicate the corresponding areas of A lines (normal aeration pattern), focal and confluent B lines (interstitial pattern), and thickening and irregularity of the pleural line in associated with B line that suggests primary lung injury.
“Lung ultrasonography may be considered a useful alternative to low-dose chest CT for diagnosis and management of COVID-19 given its ease of use, repeatability, reproducibility, absence of radiation, and immediate bedside application that obviates the need to transport the critically ill patient to the CT scanner,” said corresponding author Gary Duclos.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.